Spots Global Cancer Trial Database for chemotherapy induced anemia
Every month we try and update this database with for chemotherapy induced anemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) | NCT00931606 | Chemotherapy In... | Sotatercept Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer | NCT01284348 | Anemia Carcinoma, Non-... Carcinoma, Smal... Bladder Cancer Cancer of Head ... Uterine Cervica... | Sotatercept 15 ... Sotatercept 30 ... | 18 Years - | Merck Sharp & Dohme LLC | |
| A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy | NCT00144482 | Chemotherapy In... | recombinant hum... recombinant hum... | 20 Years - 79 Years | Chugai Pharmaceutical | |
| Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012) | NCT00931606 | Chemotherapy In... | Sotatercept Placebo | 18 Years - | Merck Sharp & Dohme LLC | |
| A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies | NCT05301517 | Chemotherapy In... | SEPO® Roxadustat | 18 Years - | FibroGen | |
| A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies | NCT05301517 | Chemotherapy In... | SEPO® Roxadustat | 18 Years - | FibroGen | |
| Darbepoetin Alfa With or Without Intravenous (IV) Iron | NCT00401544 | Anemia Non-Myeloid Mal... | darbepoetin alf... IV iron dextran | 18 Years - | Amgen | |
| A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy | NCT06075030 | Chemotherapy In... | AND017 | 18 Years - | Kind Pharmaceuticals LLC | |
| A Study to Assess Symptom Burden in Subjects With Nonmyeloid Malignancies Receiving Chemotherapy and Aranesp® | NCT00117117 | Anemia | Aranesp | 18 Years - | Amgen | |
| Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy | NCT00272662 | Chemotherapy In... Cancer | peginesatide | 18 Years - 80 Years | Affymax | |
| To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer | NCT01284348 | Anemia Carcinoma, Non-... Carcinoma, Smal... Bladder Cancer Cancer of Head ... Uterine Cervica... | Sotatercept 15 ... Sotatercept 30 ... | 18 Years - | Merck Sharp & Dohme LLC | |
| Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia | NCT04076943 | Chemotherapy In... | Roxadustat | 18 Years - | FibroGen | |
| Darbepoetin Alfa With or Without Intravenous (IV) Iron | NCT00401544 | Anemia Non-Myeloid Mal... | darbepoetin alf... IV iron dextran | 18 Years - | Amgen | |
| Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy | NCT00144131 | Anemia Cancer | Aranesp® | 18 Years - | Amgen | |
| An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks | NCT00338416 | Cancer Anemia | Epoetin alfa | 19 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| An Efficacy and Safety Study of PROCRIT (Epoetin Alfa) in Cancer Patients Receiving Chemotherapy Every Three Weeks | NCT00338416 | Cancer Anemia | Epoetin alfa | 19 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
